Pharmacogenomics
Challenges and Opportunities in Therapeutic Implementation
Published on 24. April 2013
Book
Hardback
510 pages
978-0-12-391918-2 (ISBN)
Description
Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation includes discussions and viewpoints from the academic, regulatory, pharmaceutical, clinical, socio-ethical and economic perspectives. Each chapter presents an overview of the potential or opportunity within the areas discussed and also outlines foreseeable challenges and limitations in moving pharmacogenomics into drug development and direct therapeutic applications. This edited book contains review questions for a more in-depth analysis of the implications of pharmacogenomics and discussion points to generate ideas on best to move the field forward. Clinical pearls and case studies are used to illustrate real-life experiences and both successful and unsuccessful applications. Tables, figures, and annotations are included throughout the book to facilitate understanding and further reference.
Reviews / Votes
"...a practical and indispensable resource on both the opportunities and challenges that allows readers to reflect on the future direction of pharmacogenomics while applying these observations to their own work or research."--Anticancer Research, February 2015"Lam and Cavallari bring together pharmacy and other specialists from North America, Europe, and Asia for 13 chapters aimed at scientists, clinicians, and students in health and pharmaceutical sciences. The chapters consider the translation of pharmacogenomic findings into therapeutic applications from academic, regulatory, pharmaceutical, clinical, socioethical, and economic perspectives."--Reference and Research Book News, August 2013
"This book succeeds in providing a relevant and unique perspective, by international experts in the field, on the progress and challenges facing the translation of pharmacogenomics into clinical practice. I highly recommended it to anyone with an interest in the topic, from the essential basics to its role in the future practice of medicine."--Doody.com, August 2, 2013
"...this latest state-of-the-art book on pharmacogenomics successfully tackles the objectives described by its title. The key feature of the book is the in-depth discussion on a range of challenges currently facing pharmacogenomics in the widely publicised revolution in drug therapy... the Editors and the contributors are to be congratulated for their offering and this excellent book should serve well the needs of all those interested in the potential role of pharmacogenomic revolution in personalizing therapy..." - British Journal of Clinical Pharmacology, November 5, 2013
More details
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
This book is intended for scientists and clinicians interested in pharmacogenomics implementation in academic, research, medical and pharmaceutical industry settings. Relevant fields include pharmacology, pharmaceutical sciences, genetics, molecular biology and medicine.This book may also be used as a recommended textbook for pharmacy students and graduate-level students in health and pharmaceutical science programs.
Illustrations
Approx. 175 illustrations
Dimensions
Height: 235 mm
Width: 191 mm
Weight
1200 gr
ISBN-13
978-0-12-391918-2 (9780123919182)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
Yui-Wing Francis Lam | Stuart R. Scott
Pharmacogenomics
Challenges and Opportunities in Therapeutic Implementation
Book
12/2018
2nd Edition
Academic Press
€115.50
Shipment within 15-20 days
Additional editions
Yui-Wing Francis Lam | Larissa Cavallari
Pharmacogenomics
Challenges and Opportunities in Therapeutic Implementation
E-Book
05/2014
1st Edition
Academic Press
€75.95
Available for download
Persons
Dr. Lam is Professor of Pharmacology at the University of Texas Health Science Center San Antonio (UTHSCSA). His editing experience included the first edition of Pharmacogenomics as well as being the lead editor of another published book entitled "Herbal Supplements - Drug Interactions. Scientific and Regulatory Perspectives?. He is also a co-author for a book chapter on pharmacogenetics in six consecutive editions of the textbook "Pharmacotherapy: A Pathophysiologic Approach?. Dr. Lam designed and continues to direct a graduate course "Molecular and Pharmacological Basis of Therapeutics? since 2002 for the UTHSCSA and the College of Pharmacy at the University of Texas at Austin. He has organized and participated in international and national symposia on topics related to personalized and molecular medicine, and is a scientific councilor for the Pacific Rim Association for Clinical Pharmacogenetics.
Content
SECTION 1
1 Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications
2 Translating Pharmacogenomic Research to Therapeutic Potentials
3 Governmental and Academic Efforts to Advance the Field of Pharmacogenomics (PGRN CPIC, PharmGKB)
Section 2
4a Pharmacogenomics in Cancer Therapeutics
4b A Look to the Future: Cancer epigenetics
5a Pharmacogenomics in Cardiovascular Diseases
5b A Look to the Future: Cardiovascular Pharmaco-epigenetics
6a Pharmacogenomics in Psychiatry Disorders
6b A Look to the Future: Epigenetics in psychiatric disorders and treatment
7 Role of Pharmacogenomics in Diabetes and Other Therapeutic Areas
SECTION 3
8a Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development
8b Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development
9a Incorporating Pharmacogenomics in Drug Development
Part 1: Rational study designs for pharmacogenetic research and therapy - A perspective from academia
9b Incorporating Pharmacogenomics in Drug Development
Part 2: A perspective from industry
10 Ethnobridging and Pharmacogenomics
SECTION 4
11 Beyond ELSIs - Where to from here? From 'Regulator' to Anticipating and Shaping the Innovation Trajectory in Personalized Medicine
12 The Economics of Pharmacogenomics
SECTION 5
13 Integrating Genomics into Pharmacy Education and Practice: Pharmacogenomics is not enough
1 Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications
2 Translating Pharmacogenomic Research to Therapeutic Potentials
3 Governmental and Academic Efforts to Advance the Field of Pharmacogenomics (PGRN CPIC, PharmGKB)
Section 2
4a Pharmacogenomics in Cancer Therapeutics
4b A Look to the Future: Cancer epigenetics
5a Pharmacogenomics in Cardiovascular Diseases
5b A Look to the Future: Cardiovascular Pharmaco-epigenetics
6a Pharmacogenomics in Psychiatry Disorders
6b A Look to the Future: Epigenetics in psychiatric disorders and treatment
7 Role of Pharmacogenomics in Diabetes and Other Therapeutic Areas
SECTION 3
8a Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development
8b Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development
9a Incorporating Pharmacogenomics in Drug Development
Part 1: Rational study designs for pharmacogenetic research and therapy - A perspective from academia
9b Incorporating Pharmacogenomics in Drug Development
Part 2: A perspective from industry
10 Ethnobridging and Pharmacogenomics
SECTION 4
11 Beyond ELSIs - Where to from here? From 'Regulator' to Anticipating and Shaping the Innovation Trajectory in Personalized Medicine
12 The Economics of Pharmacogenomics
SECTION 5
13 Integrating Genomics into Pharmacy Education and Practice: Pharmacogenomics is not enough